Company Filing History:
Years Active: 2021-2025
Title: Shanghai Yu - Innovator in THRβ Receptor Agonist Compounds
Introduction
Shanghai Yu is a prominent inventor based in Kunshan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of THRβ receptor agonist compounds. With a total of 5 patents to his name, Yu continues to push the boundaries of innovation in drug development.
Latest Patents
One of his latest patents is focused on a THRβ receptor agonist compound and its preparation method and use. The invention discloses a compound represented by a specific formula and a pharmaceutically acceptable salt thereof. This compound is designed to improve THRα selectivity while maintaining good THRβ agonistic activity, thereby enhancing the properties of the finished drug.
Career Highlights
Yu is currently employed at Terns, Inc., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of receptor agonist compounds in therapeutic settings.
Collaborations
Yu collaborates with various professionals in the field, including his coworker Ben Li. Their combined efforts contribute to the ongoing research and development of innovative pharmaceutical solutions.
Conclusion
Shanghai Yu is a dedicated inventor whose work in THRβ receptor agonist compounds showcases his commitment to advancing pharmaceutical science. His contributions are paving the way for improved drug therapies and better health outcomes.